← FDA Drug Approvals (Drugs@FDA)

MENTAX

NDA · New Drug Application · Sponsor: MYLAN BERTEK · Approved 1996-12-31

Drug application

FDA Application #

NDA020663

Application type

New Drug Application

Brand name

MENTAX

Generic name

Butenafine Hydrochloride

Active ingredients

BUTENAFINE HYDROCHLORIDE

Dosage form

CREAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

MYLAN BERTEK

First approval

1996-12-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown